Status:
RECRUITING
Proteomic Pattern Associated With the Diagnosis of Chronic Thromboembolic Pulmonary Hypertension
Lead Sponsor:
Centre Hospitalier Universitaire de Saint Etienne
Conditions:
Chronic Thromboembolic Pulmonary Hypertension
Eligibility:
All Genders
18+ years
Brief Summary
Chronic ThromboEmbolic Pulmonary Hypertension (CTEPH) is a rare but severe complication of pulmonary embolism (PE). CTEPH is evoked in patients with persistent dyspnea. According to international guid...
Detailed Description
However, persistent dyspnea and perfusion defects are frequent after pulmonary embolism (PE), and the accuracy of transthoracic echo (TTE) is not great for precapillary Pulmonary Hypertension (PH). T...
Eligibility Criteria
Inclusion
- Patient with a suspicion of Chronic thromboembolic pulmonary hypertension (CTEPH) with a combination of a perfusion lung scan and transthoracic perfusion scan and transthoracic echocardiography compatible with the diagnosis (according to French recommendations)
- Patients who require a right heart catheterization.
- Patient affiliated or entitled to a social security plan
- Patient having received informed information about the study informed about the study
Exclusion
- Patient with a normal perfusion lung scan
- Person under legal guardianship
Key Trial Info
Start Date :
November 9 2022
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
May 1 2027
Estimated Enrollment :
120 Patients enrolled
Trial Details
Trial ID
NCT05340023
Start Date
November 9 2022
End Date
May 1 2027
Last Update
November 24 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
CHU de SAINT-ETIENNE
Saint-Etienne, France, 42055